CPB vs CRSP · P/E 12, rev $10.25B vs rev $11.6M
Campbell’s Co (CPB) versus Crispr Therapeutics AG (CRSP) — a side-by-side from cached financials, not a winner call.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
CPB currently screens at market cap $6.46B and trailing P/E 11.8. CRSP currently screens at market cap $5.42B.
Not investment advice. Open the CPB and CRSP stock pages for the full models.
Not investment advice.